GLIOBLASTOMA, IDH-WILDTYPE
Clinical trials for GLIOBLASTOMA, IDH-WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA, IDH-WILDTYPE trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA, IDH-WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation rhythm may boost brain cancer survival and save memory
Disease control Not yet recruitingThis study tests a new way of giving radiation (TMPRT) for a fast-growing brain cancer called glioblastoma that hasn't responded well to standard chemo. About 398 adults with a specific tumor type (MGMT-unmethylated) will get either standard radiation or TMPRT, both with the chem…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New hope for brain cancer: immune booster and drug combo tested
Disease control Not yet recruitingThis study tests two drugs—retifanlimab (an immunotherapy that helps the immune system attack cancer) and DFMO (which slows tumor growth)—in people with progressive high-grade gliomas, aggressive brain tumors. The goal is to find the safest and most effective dose and see if the …
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 08, 2026 12:01 UTC